Literature DB >> 3063484

Aspects of the role of intraglomerular pressure as a cause of progressive renal damage.

M Aurell1.   

Abstract

Renal damage in hypertension was thought to be a result of excessive renal arteriolar constriction leading to ischaemia and nephron damage. However, more recent studies have shown that in animal models the aetiology is one of increased intraglomerular pressure, and there is strong evidence that this is also the case in patients with essential hypertension. The problem is therefore one of inadequate constriction of afferent arterioles allowing increased systemic pressure to be transmitted to the glomerular capillaries. Since angiotensin II preferentially constricts the efferent arterioles, and since hypertensive patients have increased renovascular sensitivity to angiotensin II, this may explain why angiotensin-converting enzyme inhibitors are the only drugs which actually lower intraglomerular pressure and why they reduce renal damage in hypertensive disease.

Entities:  

Mesh:

Year:  1988        PMID: 3063484     DOI: 10.2165/00003495-198800355-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  16 in total

1.  Renal response in man to plasma volume expansion and angiotensin.

Authors:  M Aurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1969

2.  Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels.

Authors:  R M Edwards
Journal:  Am J Physiol       Date:  1983-05

3.  Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat.

Authors:  R C Blantz; K S Konnen; B J Tucker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

4.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

Authors:  S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.

Authors:  T H Hostetter; J L Olson; H G Rennke; M A Venkatachalam; B M Brenner
Journal:  Am J Physiol       Date:  1981-07

7.  Evidence against increased glomerular pressure initiating diabetic nephropathy.

Authors:  N Bank; R Klose; H S Aynedjian; D Nguyen; L B Sablay
Journal:  Kidney Int       Date:  1987-04       Impact factor: 10.612

Review 8.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

Authors:  B M Brenner; T W Meyer; T H Hostetter
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

9.  Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.

Authors:  S Ljungman; M Aurell; M Hartford; J Wikstrand; G Berglund
Journal:  Hypertension       Date:  1983 May-Jun       Impact factor: 10.190

10.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  1 in total

1.  C-Peptide: the missing link in diabetic nephropathy?

Authors:  Lina Nordquist; John Wahren
Journal:  Rev Diabet Stud       Date:  2009-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.